Pancreatic cancer, a highly challenging malignant tumor within the digestive system, has long troubled the medical community and patient groups due to its insidious onset, rapid progression, high malignancy, and early metastasis, often leading to an unfavorable prognosis. Despite radical surgery being considered an ideal treatment approach, regrettably, most pancreatic cancer patients are diagnosed at an advanced stage, missing the optimal surgery window. Additionally, pancreatic cancer shows poor responsiveness to chemotherapy and radiotherapy, further exacerbating treatment difficulties.
However, with the rapid advancement of medical technology, cryoablation pancreatic cancer, as an innovative tumor treatment technique, is gradually emerging. It has shown significant success in fields such as liver cancer, prostate cancer, kidney cancer, and breast cancer, and its application has extended to pancreatic cancer, showing encouraging treatment prospects.
Innovative Treatment Model
For traditionally deemed inoperable pancreatic cancer, cryoablation precisely inactivates tumor tissue, not only effectively alleviating symptoms from tumor compression, such as bile duct and digestive tract obstruction but also potentially transforming palliative bypass surgery into a curative option under certain conditions, greatly improving patients'quality of life.
Minimally Invasive with Low Complications
Compared to traditional resection surgery, cryoablation pancreatic cancer offers minimal invasiveness and quick recovery, significantly reducing postoperative complications and providing a gentler treatment experience for patients.
New Strategies for Comprehensive Treatment
This technique can be flexibly combined with other treatments such as iodine-125 seed implantation to precisely target metastatic tumors, showcasing its unique value in managing complex cases.
Immune Response Activation
During cryoablation, changes in tumor cell surface antigens may trigger the body's immune response, known as "cryo-immunity," further enhancing the body's ability to eliminate residual tumor cells.
Increased Sensitivity
Studies indicate that cancer tissues treated with cryoablation show significantly increased sensitivity to subsequent chemotherapy and radiotherapy, laying a solid foundation for the successful implementation of comprehensive treatment strategies.
Percutaneous Cryoablation for Pancreatic Cancer: A retrospective study involving 32 patients and 49 ablation treatments demonstrated the broad application and good safety of this technique in different stages of pancreatic cancer, with no patient deaths or major complications, showcasing encouraging treatment outcomes.
New Breakthroughs with Laparoscopic Ultrasound Guidance: In treating locally advanced pancreatic cancer, laparoscopic ultrasound-guided cryoablation also performed excellently, not only effectively reducing tumor size but also significantly improving patients' survival status. Postoperative CT images clearly showed tumor necrosis at the center, with the condition remaining stable.
In summary, cryoablation pancreatic cancer, as a cutting-edge minimally invasive treatment, is playing an increasingly important role in the comprehensive treatment of pancreatic cancer due to its precision, efficiency, and low complication rates. With the continuous maturation of the technology and in-depth clinical research, we have reason to believe that this innovative treatment will bring hope and benefits to more pancreatic cancer patients, offering broad application prospects.
Hygea Medical Technology Co., Ltd.
Hygea Medical Technology Co., Ltd.
EN 
